Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia

American Journal of Dermatopathology

Volumn 19, Issue 3, 1997, Pages 289-293

  Nitta, Yukiko ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Systemic polyclonal plasmacytosis; T Cell malignant lymphoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; MALE; PLASMACYTOSIS; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

HUMANS; HYPERGAMMAGLOBULINEMIA; LYMPHOMA; MALE; MIDDLE AGED; PLASMA CELLS; SKIN DISEASES;

EID: 0031004022     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199706000-00016     Document Type: Article

References (16)

1. Castleman B, Thowne VW. Case records of the Massachusetts General Hospital, case 40011 (hyperplasia of mediastinal lymph nodes). N Engl J Med 1954;250:26.
2. Gaba AR, Stein RS, Sweet DL, Variakojis D, Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
3. Chen KTK. Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol 1984;8:287-93.
4. Miller RT, Mukai K, Banks PM, Frizzera G. Systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Arch Pathol Lab Med 1984;108:626-30.
5. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases. Hum Pathol 1985;16:162-72.
6. Mori S, Mouri N, Uchida T, Shimamine T. A syndrome of marked polyclonal hyperimmunoglobulinemia and severe plasma cell proliferation in lymph nodes: difference from the plasma cell type of Castleman's lymphoma (in Japanese). Nippon Mohnaikei Gakkai Zasshi 1980;20(suppl):85-94.
7. Watanabe S, Ohara K, Kukita A, Mori S. Systemic plasmacytosis: A syndrome of peculiar multiple skin eruptions generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch Dermatol 1986;122:1314-20.
8. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-6.
9. Mason DY, Cordell JL, Gaulard P, Tse AGO, Brown MH. Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CDS peptide sequence. J Clin Pathol 1992;45: 1084-8.
10. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Histochem Cytochem 1981;29:577-80.
11. Uchida T, Shikata T, Sakurui I, et al. A ease of generalized plasma cell dysplasia (in Japanese). Jpn J Cancer Clin 1979;25:731-40.
12. Katoh R, Yokoyama Y, Tohnai M, et al. A case of disseminated plasmacytosis with polyclonal hyper γ-globulinemia (in Japanese). Jpn J Clin Hematol 1982;23:76-82.
13. Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: pathological findings in 15 patients. Am J Surg Pathol 1983;7:211-31.
14. Kodama A, Tani M, Hori K, et al. Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinemia: sianificant serum interleukin-6 levels. Br J Dermatol 1992;127:49-53.
15. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990;86:592-9.
16. Nakamura H, Nakaseko C, Ishii A, et al. Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6 (in Japanese). Jpn J Clin Hematol 1993;34:212-7.